Alf treatment guidelines
Reading File
Asking for Preferences
Finding Sources
Searching PubMed
"acute liver failure"[MeSH Terms] AND management
Searching the Web
acute liver failure treatment guidelines 2024 2025 AASLD EASL
Reading File
Searching PubMed
"acute liver failure" AND treatment
Reading File
Reading File
Reading Article
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive content from multiple major textbooks. Let me compile a thorough, well-organized response.
Acute Liver Failure (ALF) — Treatment Guidelines
Definition & Classification
ALF is a clinical syndrome of severe liver injury + hepatic encephalopathy (HE) + coagulopathy (INR >1.5) in patients without pre-existing liver disease.
| Subtype | Onset of encephalopathy from symptoms |
|---|---|
| Hyperacute | Within 7 days |
| Acute | 7–21 days |
| Subacute (subfulminant) | 21 days – 26 weeks |
Shorter duration → more cerebral edema; longer duration → more portal hypertension.
Common Causes
- Acetaminophen toxicity — #1 in the US/Western Europe (~40–50%)
- Idiosyncratic drug-induced liver injury (DILI) — ~13%
- Hepatitis B — ~6%
- Autoimmune hepatitis — ~4%
- Ischemic hepatitis — ~6%
- Wilson's disease, Hepatitis A, Budd-Chiari, pregnancy
- Indeterminate — ~17%
In the developing world, viral hepatitis is the leading cause.
Initial Management
1. Immediate Steps
- Transfer immediately to a liver transplant center — progression to fulminant failure and death can be rapid.
- ICU admission for continuous monitoring of neurologic, hemodynamic, infectious, and renal status.
- Airway protection: intubate for grade 3–4 HE.
- Serial labs: INR (factor V has shortest half-life and is most sensitive), serum ammonia, pH, lactate, bilirubin, creatinine.
2. Cause-Specific Treatment
| Etiology | Treatment |
|---|---|
| Acetaminophen overdose | N-acetylcysteine (NAC) — 140 mg/kg loading dose, then 70 mg/kg q4h IV |
| Acetaminophen within 4 hours | Activated charcoal 1 g/kg orally |
| Idiosyncratic DILI, hepatitis B, autoimmune hepatitis, indeterminate | NAC also commonly recommended (limited data), especially grade 1–2 HE |
| Autoimmune hepatitis | Corticosteroids |
| Herpes simplex hepatitis | IV acyclovir |
| Wilson's disease | Urgent transplant (chelation less effective in acute setting) |
NAC replenishes glutathione and is the only proven pharmacologic antidote for acetaminophen-induced ALF. — Goldman-Cecil Medicine
3. Hepatic Encephalopathy & Cerebral Edema
The leading cause of death in fulminant hepatic failure is cerebral edema, occurring in ~80% of grade 4 HE patients.
Key point: Unlike cirrhotic HE, cerebral edema in ALF is NOT mediated by portosystemic shunting. Therefore:
- Lactulose and rifaximin are NOT proven beneficial in ALF (unlike in cirrhosis).
- Focus is on reducing ICP directly.
| Intervention | Detail |
|---|---|
| Head of bed elevation | 30 degrees |
| Sedation/paralysis | Minimize stimulation |
| Serum sodium | Maintain 140–145 mmol/L; use hypertonic saline |
| Hypertonic saline bolus | 200 mL 2.7% or 20 mL 30% for acute ICP surges |
| IV mannitol | 150 mL 20% over 20 min for acute ICP |
| Hyperventilation | Target PaCO₂ 25–30 mmHg (acute vasoconstriction) |
| Euglycemia | Maintain; avoid fever |
| CRRT | Effective for ammonia clearance; preferred over lactulose |
Ammonia >200 μmol/L correlates with increased risk of cerebral edema and intracranial hypertension.
ICP monitoring: Invasive monitors carry high bleeding risk (coagulopathy). Goal ICP <20–25 mmHg; cerebral perfusion pressure >50 mmHg. Non-invasive alternatives include transcranial Doppler and jugular venous oximetry.
CT head: Insensitive in early edema, but useful to exclude intracranial hemorrhage. If herniation or severe edema is visible on CT → transplant is contraindicated.
4. Systemic Complications Management
| Complication | Management |
|---|---|
| Coagulopathy | Vitamin K; FFP/platelets only for active bleeding or procedures |
| Renal failure | CRRT preferred (also aids ammonia clearance) |
| Infection/sepsis | Surveillance cultures; broad-spectrum antibiotics for suspected infection |
| Hemodynamic instability | Vasopressors; volume resuscitation |
| Hypoglycemia | Continuous glucose monitoring and IV dextrose |
| Acid-base | Correct metabolic acidosis; pH <7.3 is a poor prognostic marker |
5. Extracorporeal Liver Support (ELS)
Used as a bridge to transplant or recovery at specialized centers. No device has shown clear mortality benefit in randomized trials.
| System | Mechanism |
|---|---|
| MARS | Albumin dialysis removing protein-bound + water-soluble toxins |
| Prometheus | Plasma separation + adsorption + high-flux dialysis |
| SPAD | Single-pass albumin dialysis |
| High-volume plasma exchange (HVP) | Removes toxins/inflammatory mediators; small studies suggest survival benefit |
Prognosis & Transplant Decision
King's College Criteria (most widely used, PPV 80–100%)
Acetaminophen-related:
- Arterial pH <7.3 after resuscitation, OR
- INR >6.5 AND serum creatinine >3.4 mg/dL
Non-acetaminophen:
- INR >6.5 alone, OR any 3 of:
- INR >3.5
- Bilirubin >17.6 mg/dL
- Age <10 or >40 years
- Cause: drug toxicity
- Time from onset of jaundice to encephalopathy >7 days
MELD score is also used for mortality prediction; King's College Criteria may be more accurate for acetaminophen-related ALF.
Listing for Transplant
- Progression to grade II HE can trigger transplant evaluation, though this varies by center.
- Serial CT or ICP monitoring guides the decision to proceed.
- Transplant contraindicated if irreversible brain injury or uncal herniation is evident on CT.
Transplant Outcomes
- 1-year patient survival post-transplant: ~73–84%; 5-year: ~67–73%
- Spontaneous recovery (when it occurs) has superior outcomes — the challenge is identifying who will recover vs. who needs urgent transplant.
Summary Algorithm
Suspected ALF
↓
Transfer to transplant center + ICU admission
↓
Identify etiology → Cause-specific treatment (NAC, antivirals, steroids)
↓
Manage HE: ICP reduction, CRRT for ammonia, avoid lactulose
↓
Manage systemic complications (coagulopathy, renal failure, sepsis)
↓
Apply King's College Criteria / MELD → Transplant listing if indicated
↓
Consider ELS as bridge to transplant/recovery
Sources:
- Current Surgical Therapy 14e, pp. 460–461, 493
- Sabiston Textbook of Surgery, p. 1069
- Goldman-Cecil Medicine, pp. 1622–1623
- Mulholland and Greenfield's Surgery 7e
- ACG Acute Liver Failure Guidelines 2023 — Shingina et al., Am J Gastroenterol (PMID: 37377263)
- Maiwall et al., Lancet 2024 (PMID: 39098320) — comprehensive review
This is a shared conversation. Sign in to Orris to start your own chat.